Carl Anthony Evans

Insider Reports History

Entity
Individual
Location
C/O Cns Pharmaceuticals, Inc., 2100 West Loop South Ste 900, Houston, TX
Signature
/s/ Christopher Downs, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carl Anthony Evans:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CNS Pharmaceuticals, Inc. Director Restricted Stock Units 147K $44.1K $0.30 Apr 8, 2024 Direct
CNS Pharmaceuticals, Inc. Director Common stock 33.5K $10K $0.30 Feb 1, 2024 Direct
CNS Pharmaceuticals, Inc. Director Option to purchase common stock 130K Apr 8, 2024 Direct
CNS Pharmaceuticals, Inc. Director Series B Warrant to purchase common stock 112K Feb 1, 2024 Direct
CNS Pharmaceuticals, Inc. Director Series A Warrant to purchase common stock 78.8K Feb 1, 2024 Direct

Insider Reports Filed by Carl Anthony Evans

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CNSP CNS Pharmaceuticals, Inc. Apr 8, 2024 2 $0 4 Apr 10, 2024 Director
CNSP CNS Pharmaceuticals, Inc. Feb 1, 2024 3 $10K 4 Feb 6, 2024 Director
CNSP CNS Pharmaceuticals, Inc. Sep 21, 2023 1 $0 4/A Oct 12, 2023 Director
CNSP CNS Pharmaceuticals, Inc. Mar 8, 2022 1 $1.01K 4 Mar 9, 2022 Director
CNSP CNS Pharmaceuticals, Inc. Jul 15, 2021 1 $0 4 Jul 16, 2021 Director